1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol

C135H262F11N21O5 — CID 161156745

IUPAC1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol
SMILESCC(C)(C)N1C(C)(C)CCCC1(C)C.CC(C)(C)N1CC(F)(F)C1.CC(C)(C)N1CC1.CC(C)(C)N1CCC(F)(F)CC1.CC(C)(C)N1CCC(O)(C(F)(F)F)CC1.CC(C)(C)N1CCC1=O.CC(C)(C)N1CCCC1.CC(C)(C)N1CCCC1=O.CC(C)(C)N1CCOCC1.CC(F)(F)c1nc2n(n1)CCN(C(C)(C)C)C2.CC(F)(F)c1nnc2n1CCN(C(C)(C)C)C2.CC1CCN(C(C)(C)C)C1=O.CC1CCN(C(C)(C)C)CC1.CC1CCN(C(C)(C)C)CC1.CC1CN(C(C)(C)C)C1
InChIInChI=1S/C13H27N.2C11H18F2N4.C10H18F3NO.2C10H21N.C9H17F2N.C9H17NO.C8H17NO.C8H15NO.2C8H17N.C7H13F2N.C7H13NO.C6H13N/c1-11(2,3)14-12(4,5)9-8-10-13(14,6)7;1-10(2,3)16-5-6-17-8(7-16)14-15-9(17)11(4,12)13;1-10(2,3)16-5-6-17-8(7-16)14-9(15-17)11(4,12)13;1-8(2,3)14-6-4-9(15,5-7-14)10(11,12)13;2*1-9-5-7-11(8-6-9)10(2,3)4;1-8(2,3)12-6-4-9(10,11)5-7-12;1-7-5-6-10(8(7)11)9(2,3)4;1-8(2,3)9-4-6-10-7-5-9;1-8(2,3)9-6-4-5-7(9)10;1-7-5-9(6-7)8(2,3)4;1-8(2,3)9-6-4-5-7-9;1-6(2,3)10-4-7(8,9)5-10;1-7(2,3)8-5-4-6(8)9;1-6(2,3)7-4-5-7/h8-10H2,1-7H3;2*5-7H2,1-4H3;15H,4-7H2,1-3H3;2*9H,5-8H2,1-4H3;4-7H2,1-3H3;7H,5-6H2,1-4H3;4-7H2,1-3H3;4-6H2,1-3H3;7H,5-6H2,1-4H3;4-7H2,1-3H3;4-5H2,1-3H3;4-5H2,1-3H3;4-5H2,1-3H3
InChIKeyUPJWLEPNHDYBRF-UHFFFAOYSA-N
MW2468.70 g/mol
LogP29.21
Rot. Bonds2

About 1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol

1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol (PubChem CID 161156745) has the molecular formula C135H262F11N21O5 and a molecular weight of 2468.70 g/mol. Its IUPAC name is 1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol.

Molecular Properties

Compound Name1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol
PubChem CID161156745
Molecular FormulaC135H262F11N21O5
Molecular Weight2468.70 g/mol
Exact Mass2467.07
IUPAC Name1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol
SMILESCC(C)(C)N1C(C)(C)CCCC1(C)C.CC(C)(C)N1CC(F)(F)C1.CC(C)(C)N1CC1.CC(C)(C)N1CCC(F)(F)CC1.CC(C)(C)N1CCC(O)(C(F)(F)F)CC1.CC(C)(C)N1CCC1=O.CC(C)(C)N1CCCC1.CC(C)(C)N1CCCC1=O.CC(C)(C)N1CCOCC1.CC(F)(F)c1nc2n(n1)CCN(C(C)(C)C)C2.CC(F)(F)c1nnc2n1CCN(C(C)(C)C)C2.CC1CCN(C(C)(C)C)C1=O.CC1CCN(C(C)(C)C)CC1.CC1CCN(C(C)(C)C)CC1.CC1CN(C(C)(C)C)C1
InChIInChI=1S/C13H27N.2C11H18F2N4.C10H18F3NO.2C10H21N.C9H17F2N.C9H17NO.C8H17NO.C8H15NO.2C8H17N.C7H13F2N.C7H13NO.C6H13N/c1-11(2,3)14-12(4,5)9-8-10-13(14,6)7;1-10(2,3)16-5-6-17-8(7-16)14-15-9(17)11(4,12)13;1-10(2,3)16-5-6-17-8(7-16)14-9(15-17)11(4,12)13;1-8(2,3)14-6-4-9(15,5-7-14)10(11,12)13;2*1-9-5-7-11(8-6-9)10(2,3)4;1-8(2,3)12-6-4-9(10,11)5-7-12;1-7-5-6-10(8(7)11)9(2,3)4;1-8(2,3)9-4-6-10-7-5-9;1-8(2,3)9-6-4-5-7(9)10;1-7-5-9(6-7)8(2,3)4;1-8(2,3)9-6-4-5-7-9;1-6(2,3)10-4-7(8,9)5-10;1-7(2,3)8-5-4-6(8)9;1-6(2,3)7-4-5-7/h8-10H2,1-7H3;2*5-7H2,1-4H3;15H,4-7H2,1-3H3;2*9H,5-8H2,1-4H3;4-7H2,1-3H3;7H,5-6H2,1-4H3;4-7H2,1-3H3;4-6H2,1-3H3;7H,5-6H2,1-4H3;4-7H2,1-3H3;4-5H2,1-3H3;4-5H2,1-3H3;4-5H2,1-3H3
InChIKeyUPJWLEPNHDYBRF-UHFFFAOYSA-N
XLogP29.21
TPSA190.46 Ų
H-Bond Donors1
H-Bond Acceptors23
Rotatable Bonds2
Heavy Atoms172
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002468.70
LogP ≤ 529.21
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1023

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Three-membered_heterocycle', 'substructure': 'N/A'}

Analyze 1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol?
The IUPAC name of 1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol (CID 161156745) is 1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol.
What is the SMILES notation for 1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol?
The canonical SMILES for 1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol is CC(C)(C)N1C(C)(C)CCCC1(C)C.CC(C)(C)N1CC(F)(F)C1.CC(C)(C)N1CC1.CC(C)(C)N1CCC(F)(F)CC1.CC(C)(C)N1CCC(O)(C(F)(F)F)CC1.CC(C)(C)N1CCC1=O.CC(C)(C)N1CCCC1.CC(C)(C)N1CCCC1=O.CC(C)(C)N1CCOCC1.CC(F)(F)c1nc2n(n1)CCN(C(C)(C)C)C2.CC(F)(F)c1nnc2n1CCN(C(C)(C)C)C2.CC1CCN(C(C)(C)C)C1=O.CC1CCN(C(C)(C)C)CC1.CC1CCN(C(C)(C)C)CC1.CC1CN(C(C)(C)C)C1.
What is the InChIKey of 1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol?
The InChIKey is UPJWLEPNHDYBRF-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H27N.2C11H18F2N4.C10H18F3NO.2C10H21N.C9H17F2N.C9H17NO.C8H17NO.C8H15NO.2C8H17N.C7H13F2N.C7H13NO.C6H13N/c1-11(2,3)14-12(4,5)9-8-10-13(14,6)7;1-10(2,3)16-5-6-17-8(7-16)14-15-9(17)11(4,12)13;1-10(2,3)16-5-6-17-8(7-16)14-9(15-17)11(4,12)13;1-8(2,3)14-6-4-9(15,5-7-14)10(11,12)13;2*1-9-5-7-11(8-6-9)10(2,3)4;1-8(2,3)12-6-4-9(10,11)5-7-12;1-7-5-6-10(8(7)11)9(2,3)4;1-8(2,3)9-4-6-10-7-5-9;1-8(2,3)9-6-4-5-7(9)10;1-7-5-9(6-7)8(2,3)4;1-8(2,3)9-6-4-5-7-9;1-6(2,3)10-4-7(8,9)5-10;1-7(2,3)8-5-4-6(8)9;1-6(2,3)7-4-5-7/h8-10H2,1-7H3;2*5-7H2,1-4H3;15H,4-7H2,1-3H3;2*9H,5-8H2,1-4H3;4-7H2,1-3H3;7H,5-6H2,1-4H3;4-7H2,1-3H3;4-6H2,1-3H3;7H,5-6H2,1-4H3;4-7H2,1-3H3;4-5H2,1-3H3;4-5H2,1-3H3;4-5H2,1-3H3.
What are the key properties of 1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol?
1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol has a molecular weight of 2468.70 g/mol, XLogP of 29.21, 2 rotatable bonds, 1 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 1-tert-butylazetidin-2-one;1-tert-butylaziridine;1-tert-butyl-3,3-difluoroazetidine;7-tert-butyl-2-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[1,5-a]pyrazine;7-tert-butyl-3-(1,1-difluoroethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;1-tert-butyl-4,4-difluoropiperidine;1-tert-butyl-3-methylazetidine;bis(1-tert-butyl-4-methylpiperidine);1-tert-butyl-3-methylpyrrolidin-2-one;4-tert-butylmorpholine;1-tert-butylpyrrolidine;1-tert-butylpyrrolidin-2-one;1-tert-butyl-2,2,6,6-tetramethylpiperidine;1-tert-butyl-4-(trifluoromethyl)piperidin-4-ol is sourced from PubChem (CID 161156745), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).